Floatz logo

Cyclophosphamide

Mesothelin-positive Advanced Malignant Solid Tumors

Zhejiang UniversitySmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

4 Active assets in the Mesothelin-positive Advanced Malignant Solid Tumors cohort.

Asset / SponsorPhaseRating
Anti-Mesothelin Car-T Cells
Zhejiang University
Phase 1CC
ct-95
Context Therapeutics Inc.
Phase 1CC
Uclm802 Cell
Zhejiang University
Phase 1CC
Fludarabine
Zhejiang University
N/AD

Same molecule, other indications

Cyclophosphamide is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
mycosis fungoidesDormant
BBB
Indicative ·
78 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →